MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on August 1, 2006; DOI: 10.1124/mol.106.025403


This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.106.025403v1
70/5/1681    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martinez-Jimenez, C. P.
Right arrow Articles by Jover, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martinez-Jimenez, C. P.
Right arrow Articles by Jover, R.


Received for publication April 6, 2006.
Revised July 31, 2006.
Accepted for publication August 1, 2006.

Transcriptional activation of CYP2C9, CYP1A1 and CYP1A2 by HNF4{alpha} requires coactivators PGC1{alpha} and SRC1

Celia P. Martinez-Jimenez 1, Jose V. Castell 1, Maria Jose Gomez-Lechon 1, Ramiro Jover 2*

1 Hospital Universitario La Fe 2 Universidad de Valencia

* Address correspondence to: E-mail: ramiro.jover{at}uv.es

Abstract

HNF4{alpha} is a key transcription factor for the constitutive expression of CYPs in the liver. However, human hepatoma HepG2 cells show a high level of HNF4{alpha} but express only marginal CYP levels. We found that the HNF4{alpha}-mediated CYP transcription in HepG2 is impaired by the low level of coactivators PGC1{alpha} and SRC1. Reporter assays with a chimeric CYP2C9-LUC construct demonstrated that the sole transfection of coactivators induced luciferase activity in HepG2 cells. In HeLa cells however, CYP2C9-LUC activity only significantly increased when coactivators were cotransfected with HNF4{alpha}. A deletion mutant lacking the two proximal HNF4{alpha} binding sites in the CYP2C9 promoter did not respond to PGC1{alpha} or SRC1, demonstrating that coactivators were acting through HNF4{alpha} response elements. Adenovirus-mediated transfection of PGC1{alpha} in human hepatoma cells caused a significant dose-dependent increase in CYP2C9, CYP1A1 and CYP1A2, as well as in the positive control CYP7A1. PGC1{alpha} also showed a moderate activating effect on CYP3A4, CYP3A5 and CYP2D6. Adenoviral transfection of SRC1 had a lessened effect on CYP genes. Chromatin immunoprecipitation assay demonstrated in vivo binding of HNF4{alpha} and PGC1{alpha} to HNF4{alpha} response sequences in the CYP2C9 promoter and to three new regulatory regions in the common 23.3 kb spacer sequence of the CYP1A1/2 cluster. Insulin treatment of HepG2 and human hepatocytes caused repression of PGC1{alpha} and a concomitant down-regulation of CYPs. Our results establish the importance of coactivators PGC1{alpha} and SRC1 for the hepatic expression of human CYPs, and uncover a new HNF4{alpha}-dependent regulatory mechanism to constitutively control the CYP1A1/2 cluster.


Key words: Transcriptional coactivators, DNA binding sites, Promoter analysis, Regulation of gene expression, Cytochrome P450, Regulation - transcriptional


This article has been cited by other articles:


Home page
J DAIRY SCIHome page
C. O. Lemley, S. T. Butler, W. R. Butler, and M. E. Wilson
Short Communication: Insulin Alters Hepatic Progesterone Catabolic Enzymes Cytochrome P450 2C and 3A in Dairy Cows
J Dairy Sci, February 1, 2008; 91(2): 641 - 645.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
W. Hu, C. Sorrentino, M. S. Denison, K. Kolaja, and M. R. Fielden
Induction of Cyp1a1 Is a Nonspecific Biomarker of Aryl Hydrocarbon Receptor Activation: Results of Large Scale Screening of Pharmaceuticals and Toxicants in Vivo and in Vitro
Mol. Pharmacol., June 1, 2007; 71(6): 1475 - 1486.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics